PRO-122: Clinical Trials

2 trials of PRO-122, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Terminated 1

Follow PRO-122: new trials by email Literature Review of PRO-122 trials Research Report on PRO-122

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)
PRO-122, Timolol eye drops, Dorzolamide-Timolol Ophthalmic - Primary Open-angle Glaucoma
Phase 3TerminatedLaboratorios Sophia S.A de C.V.512017-11-062025-03-06
Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK)
PRO-122, Krytantek Ofteno® - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 3CompletedLaboratorios Sophia S.A de C.V.602016-04-012019-12-09

Conditions studied

Glaucoma (2)  ·  Glaucoma, Open-Angle (2)  ·  Ocular Hypertension (1)

Sponsors

Laboratorios Sophia S.A de C.V. (2)

Countries

Colombia (1)  ·  Mexico (1)

Top investigators

Leopoldo Baiza, MD (1)

Results publications

PMID 29680880, PMID 41737851